Publications by authors named "Laure Layani"

Claim this Profile
A
A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury.
Anthony Marmarou, Martine Guy, Laine Murphey, Francis Roy, Laure Layani

J Neurotraumaยท December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis